A multicenter retrospective investigation across three intensive care cohorts has found that the relationship between corticosteroid administration timing and clinical outcomes in septic shock differs significantly according to patients’ longitudinal hemodynamic trajectory phenotypes. Published in the Journal of Clinical Monitoring and Computing, the research analyzed adult patients requiring vasopressor support across the Medical Information Mart for Intensive Care-IV, the eICU Collaborative Research Database, and the PKUPH Intensive care Network and Evaluation System. Rather than treating septic shock as a uniform clinical entity with a standardized treatment window, the investigators clustered temporal patterns of cardiovascular responsiveness over one hundred sixty-eight hours following sepsis onset. In the primary derivation cohort, patients whose cardiovascular status persistently deteriorated exhibited lower twenty-eight-day mortality, shorter hospital stays, and expedited liberation from mechanical ventilation when corticosteroids were initiated between six and twenty-four hours after sepsis onset compared with initiation within the first six hours. Conversely, patients presenting with stable or recovering cardiovascular trajectories derived no apparent survival advantage from delayed corticosteroid therapy, demonstrating that dynamic physiological phenotypes may explain longstanding contradictions regarding adjunctive steroid timing.
Despite standardized international resuscitation bundles, contemporary intensive care cohorts consistently document mortality rates exceeding thirty percent among adult patients requiring vasopressor infusion. For more than four decades, adjunctive corticosteroids have been deployed to exploit their anti-inflammatory, vasoconstrictive, and immunomodulatory properties, yet major clinical trials have yielded conflicting results. Landmark investigations such as APROCCHSS demonstrated significant reductions in ninety-day mortality using combined hydrocortisone and fludrocortisone, whereas the ADRENAL trial recorded faster shock resolution without any survival benefit from hydrocortisone alone, and the CORTICUS trial showed no survival difference when enrolling patients up to seventy-two hours following shock onset. While subsequent meta-analyses of randomized trials suggested a modest overall reduction in short-term mortality, clinical outcomes have exhibited pronounced heterogeneity that conventional study designs could not resolve.
A parallel debate has centered on the therapeutic window for corticosteroid administration, with several observational studies endorsing an aggressive earlier-is-better strategy. Prior published analyses reported reductions in twenty-eight-day mortality, shorter durations of vasopressor support, and abbreviated intensive care lengths of stay when corticosteroids were started within six or twelve hours of shock onset, whereas delays beyond twelve hours were associated with increased short-term and long-term mortality. However, these earlier investigations evaluated the septic shock population as a physiologically homogeneous group, overlooking complex patient-level variation. Emerging work in critical care transcriptomics and electronic health records has demonstrated that clinical endotypes and biological response signatures respond differently to corticosteroid exposure. In post-hoc evaluations of trials like VANISH, patients categorized into specific transcriptomic endotypes suffered higher mortality when assigned to hydrocortisone compared with placebo, underscoring that both the direction and magnitude of treatment effects depend on underlying biological states that conventional bedside markers fail to capture.
To establish a clinically accessible stratification framework grounded directly in bedside physiology rather than costly transcriptomic assays, the research team focused on dynamic cardiovascular behavior using the Blood Pressure-Vasopressor Index. Defined as the ratio of mean arterial pressure to the Vasoactive-Inotropic Score, this composite metric evaluates vascular responsiveness by balancing the arterial pressure achieved against the total vasoactive and inotropic burden required to maintain that pressure. The score mathematically aggregates hourly doses of norepinephrine, epinephrine, dopamine, dobutamine, milrinone, and vasopressin. While mean arterial pressure alone may appear adequate despite rapidly escalating vasopressor infusions, and isolated drug dosages ignore achieved circulatory performance, the combined index captures real-time vascular tone. The researchers applied the TimeSeriesKMeans algorithm from the tslearn package, employing Dynamic Time Warping without a global warping-window constraint alongside z-score normalization to analyze standardized index trajectories over seven days in five thousand four hundred forty-three patients from the derivation database.
Unsupervised clustering identified two distinct hemodynamic phenotypes in the derivation cohort, categorized as Deteriorated and Improved. The Deteriorated phenotype accounted for two thousand eighty-two patients, or thirty-eight percent of the cohort, and was characterized by persistently declining vascular index curves and substantially higher twenty-eight-day mortality on adjusted Cox regression analyses. The Improved phenotype comprised three thousand three hundred sixty-one individuals, representing sixty-two percent of patients, who exhibited stable or progressively rising trajectory curves and superior baseline survival. Notably, conventional baseline parameters documented at sepsis onset, including Sequential Organ Failure Assessment scores, serum lactate, and most routine laboratory variables, were largely comparable between the two groups. Although deteriorating patients in the derivation cohort were slightly older with marginally lower body weight and higher baseline bilirubin, their shared initial severity scores demonstrated that standard static metrics could not distinguish between patients destined for sustained hemodynamic decline and those on a trajectory toward spontaneous recovery.
Within the derivation cohort, the researchers evaluated corticosteroid timing using inverse probability of treatment weighting coupled with cause-specific Cox proportional hazards models adjusted for baseline age, comorbidity burden, organ failure scores, lactate, hemoglobin, and cumulative twenty-four-hour steroid dose. Among patients presenting the Deteriorated phenotype who received at least one hundred milligrams of hydrocortisone-equivalent within the first day, late corticosteroid initiation between six and twenty-four hours was associated with a twelve percent reduction in twenty-eight-day mortality compared with early initiation within six hours, yielding an adjusted hazard ratio of 0.88 with a ninety-five percent confidence interval of 0.78 to 0.98. Late treatment in this group was likewise associated with significantly shorter hospital length of stay, exhibiting a cause-specific hazard ratio of 0.72, and an accelerated liberation from mechanical ventilation with a hazard ratio of 0.65. Conversely, patients categorized into the Improved phenotype experienced no statistically significant difference in twenty-eight-day mortality or hospital stay between late and early steroid timing, although ventilation duration remained modestly shorter.
External validation conducted in the eICU Collaborative Research Database comprising three hundred five patients and the PINES registry comprising four hundred sixty-five patients confirmed the presence of the two dynamic trajectory shapes across geographically distinct healthcare environments. However, the mortality associations observed in the derivation cohort could not be consistently replicated within the smaller validation populations, where limited patient numbers within stratified subgroups produced wide confidence intervals. Across random-effects meta-analysis combining available cohorts, the pooled hazard ratio for twenty-eight-day mortality in the Deteriorated phenotype was 0.89 with a ninety-five percent confidence interval of 0.79 to 0.99 and an inconsistency index of zero percent, though the authors emphasized that this pooled estimate remains heavily weighted by the larger derivation dataset. In contrast, the association between late steroid timing and reduced mechanical ventilation duration demonstrated greater consistency, achieving independent statistical significance within the deteriorating subgroup of the PINES validation cohort and yielding a pooled hazard ratio of 0.65 across the combined populations.
To explore potential physiological mechanisms underlying the observed divergence in clinical outcomes, the investigators conducted a propensity score-matched analysis of acute hemodynamic responses within the derivation database. Matching patients one-to-one on baseline trajectory characteristics from hours zero to six, the authors tracked hourly slope changes during the subsequent six-to-twelve-hour response window. Among matched pairs exhibiting the Deteriorated phenotype, patients receiving delayed corticosteroids displayed a statistically significant positive trajectory slope of plus 0.0006 units per hour, whereas those given steroids within the initial six hours continued on a negative trajectory of minus 0.0025 units per hour. In the Improved phenotype, response slopes showed no significant divergence between timing strata. The authors noted that an early surge of endogenous cortisol accompanied by down-regulated or saturated glucocorticoid receptor expression during initial shock resuscitation represents a biologically plausible explanation for differential timing responses, although the observational dataset contained no direct hormone or receptor quantification to confirm this hypothesis.
The study incorporated extensive sensitivity analyses to examine the robustness of its trajectory framework and treatment thresholds. Applying an alternative twelve-hour timing threshold defining early administration as twelve hours or fewer and late administration as greater than twelve to twenty-four hours yielded findings directionally compatible with the primary six-hour model. Analysis of absolute ventilation duration confirmed that median mechanical ventilation was abbreviated from 8.2 days in early-treated deteriorating patients to 5.2 days in late-treated individuals, with twenty-eight-day extubation rates reaching 80.6 percent compared with 72.0 percent. When patients requiring tracheostomy or experiencing accidental extubation were excluded, late corticosteroid therapy maintained its association with earlier liberation. Furthermore, an early recognition analysis using initial trajectory data demonstrated that machine learning classifiers could approximate final seven-day phenotype membership with an area under the receiver operating characteristic curve of 0.735 using six-hour data and 0.825 using twelve-hour data, highlighting the potential for near-real-time trajectory classification.
Despite these compelling findings, the researchers emphasized that the retrospective, observational nature of the work precludes definitive causal conclusions, highlighting that timing associations must be interpreted as hypothesis-generating rather than prescriptive clinical guidance. Unmeasured confounding factors, such as the exact timing of surgical source control, variations in volume resuscitation, baseline plasma cortisol, and local ventilator weaning protocols, could not be completely eliminated. Furthermore, variations in corticosteroid formulations, including hydrocortisone, methylprednisolone, and dexamethasone, as well as sparse fludrocortisone utilization across participating hospitals, may have influenced subgroup findings. Because full trajectory phenotypes were established over a seven-day observation period, prospective bedside deployment requires rigorous validation of early predictive algorithms before dynamic phenotyping can actively guide therapeutic timing in clinical practice. The investigators concluded that future prospective clinical trials evaluating corticosteroid regimens in septic shock should incorporate dynamic cardiovascular trajectories into trial stratification schemes to resolve long-standing clinical uncertainties.
Subject of Research: Hemodynamic trajectory phenotyping and corticosteroid administration timing in adult septic shock
Article Title: Hemodynamic trajectory phenotypes may modify associations between corticosteroid timing and outcomes in septic shock
Article References: Shen, J., Sun, C., Wang, G., Zhao, X., Li, S., & Zhu, F. (2026). Hemodynamic trajectory phenotypes may modify associations between corticosteroid timing and outcomes in septic shock. Journal of Clinical Monitoring and Computing. https://doi.org/10.1007/s10877-026-01513-0
Image Credits: AI Generated
DOI: 10.1007/s10877-026-01513-0
Keywords: septic shock, corticosteroid timing, hemodynamic trajectories, Blood Pressure-Vasopressor Index, dynamic time warping, MIMIC-IV, eICU-CRD, PINES database, 28-day mortality, mechanical ventilation, intensive care medicine, vasopressors, phenotype clustering, Vasoactive-Inotropic Score, hydrocortisone, inverse probability weighting, critical care research
News Source: Ophelia Keating. (November 18, 2026). Delayed Corticosteroids Linked to Improved Survival in Deteriorating Septic Shock Phenotype. Scienmag.



